Oh, phenibut, that little Russian chemical cousin of GABA, you sneaky nootropic, you. Since the 1960s, you’ve been parading around, offering the promise of a sharper brain and a calmer demeanor. And what’s more, you’re just a click and a credit card away from anyone with internet access in the good ol’ US of A, because who needs prescriptions and regulations, right?

But wait, there’s a plot twist! With fame comes a dark side, and phenibut, you’re no exception. Reports of acute intoxication and withdrawal are popping up like mushrooms after rain. So, in this riveting review, we dive into the pharmacological rollercoaster that is phenibut, dissecting the ins and outs of intoxication, the joys of withdrawal, and the ever-so-clear regulatory landscape.

Now, gather ’round for a tale of 29 brave souls who danced with phenibut withdrawal and lived to tell the tale, thanks to our heroes: baclofen, benzodiazepines, and phenobarbital. These knights in shining pharmaceutical armor were deployed in various combinations, with a merry band of ancillary meds like antipsychotics and gabapentin joining the fray. Some patients got cozy with baclofen tapers, while others bid adieu to benzodiazepines or phenobarbital. And for those with a penchant for seizures, phenobarbital might just be your new best friend.

But let’s not forget, as long as phenibut is living its best legal life, the party’s not over. More intoxication and withdrawal shenanigans are on the horizon. And since drug screening for phenibut is about as common as a unicorn sighting, it’s up to the emergency department’s finest to play detective with a patient’s medication history.

So, dear clinicians, if you find yourself scratching your head over a patient with symptoms as clear as mud, it might just be phenibut’s handiwork. Don’t be shy to phone a friend, be it an addiction specialist or a toxicologist, because it takes a village to manage a phenibut fiasco.